The use of recreational substances in drug-facilitated sexual assaults (DFSA) has drawn attention during the last few decades and has become a significant problem worldwide. Public awareness in context to DFSA is restricted, therefore early recognition and management of such crucial cases became problems for non-forensic professionals and on-spot investigators. Although forensic laboratories are using conventional chromatographic and spectroscopic methods for DFSA drug detection, expertise requirement in result analysis and time consuming detection method always calls for rapid and on-spot sensing platform. Therefore, numerous researches have been focused on developing sensors for sensitive DFSA associated drug detection. In this review, we summarize previous technological advancements in sensor development for on-spot DFSA drug detection and futuristic potential approaches for rapid analytical methods. Our study focuses on sensing of DFSA drugs, namely Rohypnol® (flunitrazepam), Gamma Hydroxy Butyrate (GHB) and ketamine followed by potential limitations for real life implementations of the sensors. In conclusion, we summarizeare summarizing attempts made in sensing technonolgy development for on-spot and rapid DFSA drugs detection. To the best of our knowledge,to date no effort has been made in this direction, hence our study may provide detailed insight of forensic science and analytical chemistry. We believe it will motivate the scientific community to make additional effort in this emerging interdisciplinary field for DFSA associated drugs detection.

在过去的几十年里，在毒品辅助性侵犯 (DFSA) 中使用娱乐性物质引起了人们的注意，并已成为世界范围内的一个重大问题。公众对 DFSA 的认识受到限制，因此对此类关键案件的早期识别和管理成为非法医专业人员和现场调查人员的问题。虽然法医实验室使用传统的色谱和光谱方法进行 DFSA 药物检测，但结果分析和耗时检测方法的专业要求总是需要快速和现场传感平台。因此，许多研究都集中在开发用于敏感 DFSA 相关药物检测的传感器。在这次审查中，我们总结了用于现场 DFSA 药物检测的传感器开发方面的先前技术进步和用于快速分析方法的未来潜在方法。我们的研究侧重于 DFSA 药物的传感，即 Rohypnol®（氟硝西泮）、羟基丁酸伽玛 (GHB) 和氯胺酮，随后是传感器在现实生活中实施的潜在限制。总之，我们总结总结了在用于现场和快速 DFSA 药物检测的传感技术开发方面所做的尝试。据我们所知，迄今为止还没有在这方面做出任何努力，因此我们的研究可能会提供法医学和分析化学的详细见解。我们相信这将激励科学界在这个新兴的跨学科领域为 DFSA 相关药物检测做出额外的努力。